-
Study aim
-
Determining the effectiveness of TDCS on improvement of OCD symptoms, quality of life, depression, and cognitive functions in patients with obsessive-compulsive disorder
-
Design
-
A randomized (using random numbers table), double-blind, sham controlled clinical trial with a parallel group, 30 patients (15 patients in the sham and 30 patients, 15 in each stimulation group).Both participants and evaluators will be unaware of the allocation of study groups.
-
Settings and conduct
-
The statistical population of the present study will include patients with obsessive-compulsive disorder who refer to counseling and psychotherapy centers and psychiatric clinics in Ardabil in 2020.
In the stimulation groups (1 mA and 2 mA), the samples will be treated for 10 sessions.
Patients will be treated daily for 20 minutes.
In the sham group, no therapeutic intervention will be performed with the TDCS device. Patients in both groups will be done pre-tested, post-test and follow up before, after and one month after intervention with Yale Brown, SF-36, Beck-II, Wisconsin cards and QEEG. Control group will be treated with tdcs for 10 sessions after the end of trial.
-
Participants/Inclusion and exclusion criteria
-
The research samples will include 45 patients with obsessive-compulsive disorder who will be selected based on the study inclusion/exclusion criteria.
Inclusion criteria:Age 18 to 40, literacy to read and write, OCD according to DSM-5 criteria, Willingness to participate in the study
Exclusion criteria: Severe mental illness, History of stroke, serious neurologic symptoms including seizures, Brain Surgery, Brain tumor, CSF shunt in the brain, snail planting, physical tools in the body, serious physical illness,
-
Intervention groups
-
15 in the 1 mA group, 15 in the 2 mA group and 15 in the sham group.
-
Main outcome variables
-
Improvement of OCD symptoms, quality of life, depression, and cognitive functions in patients with OCD disorder